Prolia Pricing: A High Bar For Osteoporosis But Room To Tap Oncology Potential

With a wholesale acquisition cost of $1,650 a year for Prolia, Amgen has effectively sacrificed the first-line treatment market for osteoporosis in favor of long-term potential in future indications.